Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Transplantation. 2017 Oct;101(10):2429–2439. doi: 10.1097/TP.0000000000001619

Figure 2. Patient and Allograft Survival stratified by DSA and B-flow Crossmatch at Baseline.

Figure 2

The mean follow-up was similar among groups and was 4.1±1.9 years, p=0.82. Patient and overall allograft survival were similar among groups, p=0.82 and p=0.06 respectively. Lower death-censored allograft survival was observed in the +DSA/high+XM group, p<0.01. Death-censored allograft survival was similar in other groups,